Editorial Board
Oleg Demidov MD, Ph.D
INSERM UMR1231 (U866), University of Burgundy, France · France
Editorial leadership for International Journal of Chemotherapy Research and Practice
Research interests
- Anti-Cancer Therapy
- Dna Damage
- Cell Death
- Senescence
- P53 Pathway
- Mapk
- Phosphatases
- Immunotherapy
Biography
Brief Chronology of Employment:
- Since 2009 Researcher CR1, INSERM U866, Dijon
- 2005-2009 Research Fellow, Institute of Molecular and Cell Biology, Singapore
- 2000 - 2005 Visiting Fellow, Laboratory of Cell Biology , NCI, NIH, Bethesda, MD, USA
- 1999 - 2000 Research Scientist, Institute of Cytology, St.Petersburg, Russia.
- 1996 -1999 PhD thesis research.
- 1999 PhD in Physiology and Biochemistry; Military Medical Academy and Institute of Cytology, Russian Academy of Sciences, St.Petersburg, Russia.
PhD thesis:
"Heat shock proteins (HSP70) in cardiosurgery patients"
- 1994-1996 MD practice in Internal Medicine.
- 1994 MD, Military Medical Academy, St.Petersburg, Russia.
Selected publications
- Accumulation of storage proteins in plant seeds is mediated by amyloid formation 2020 cited 90×
- TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling 2020 cited 85×
- Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses 2021 cited 35×
- p16High senescence restricts cellular plasticity during somatic cell reprogramming 2023 cited 29×
- The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs 2024 cited 27×
- RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy 2022 cited 14×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCP for your work?
This journal is guided by Oleg Demidov (INSERM UMR1231 (U866), University of Burgundy, France) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.